Brendan Smith

Brendan Smith

Net worth: 427 164 $ as of 2024-02-28

48 year
Health Technology
Consumer Services
Commercial Services

Profile

Currently, Brendan Smith holds the position of Senior VP, Chief Financial & Accounting Officer at CRISPR Therapeutics AG. In the past Mr. Smith was Chief Financial Officer & Head-Corporate Strategy at Translate Bio, Inc. and Partner & Associate Director at The Boston Consulting Group, Inc. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 5,072 ( 0.01% ) 427 164 $ 2024-02-28

Former positions of Brendan Smith

CompaniesPositionEnd
CRISPR THERAPEUTICS AG Director of Finance/CFO 2023-03-13
TRANSLATE BIO, INC. Director of Finance/CFO 2021-09-13
Corporate Officer/Principal 2021-02-28
Pfizer AG Director/Board Member -
See the detail of Brendan Smith's experience

Training of Brendan Smith

Worcester Polytechnic Institute Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brendan Smith's experience

Connections

70

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CRISPR THERAPEUTICS AG

Health Technology

Private companies3

Health Technology

Commercial Services

Pfizer AG

See company connections
  1. Stock
  2. Insiders
  3. Brendan Smith